Anisometropia at Age 5 Years After Unilateral Intraocular Lens Implantation During Infancy in the Infant Aphakia
David Weakley1, George Cotsonis2, M Edward Wilson3
1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.
Insights
Most infants who received intraocular lens (IOL) implantation for unilateral cataracts developed significant anisometropia by age 5. Glaucoma further increased this refractive difference, highlighting challenges in infant eye care.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Refractive Error
Background:
- Unilateral congenital cataracts require early intervention, often involving intraocular lens (IOL) implantation.
- Achieving emmetropia in infants post-IOL implantation is complex due to ongoing eye growth and refractive changes.
- Anisometropia, a significant difference in refractive error between eyes, is a common concern after pediatric cataract surgery.
Purpose of the Study:
- To determine the prevalence of anisometropia at age 5 years in infants treated for unilateral cataracts with IOL implantation.
- To investigate factors influencing anisometropia, specifically the impact of developing glaucoma.
Main Methods:
- Prospective randomized clinical trial within the Infant Aphakia Treatment Study (IATS).
- Fifty-seven infants with unilateral cataracts underwent randomized IOL implantation targeting either +8D or +6D postoperative refractive error based on age at surgery (28 to <48 days or 48-210 days, respectively).
- Anisometropia was assessed at age 5 years; 6 patients were excluded from analysis.
Main Results:
- The majority of pseudophakic eyes exhibited significant anisometropia by age 5 years, with a median anisometropia of -3.50D (IQR -8.25D to -0.88D).
- Patients who developed glaucoma in the treated eye showed significantly greater anisometropia (median -8.25D) compared to those without glaucoma (median -2.75D; P=0.005).
- Refractive errors at age 5 years were -2.25D (IQR -5.13D to +0.88D) in treated eyes and +1.50D (IQR +0.88D to +2.25D) in fellow eyes.
Conclusions:
- Significant anisometropia is prevalent at age 5 years following unilateral IOL implantation in infants with cataracts.
- The development of glaucoma in the treated eye is associated with increased anisometropia.
- Variability in infant eye growth and myopic shift presents ongoing challenges for achieving optimal refractive outcomes with early IOL implantation.
Purpose:
To report the prevalence of anisometropia at age 5 years after unilateral intraocular lens (IOL) implantation in infants.
Design:
Prospective randomized clinical trial.
Methods:
Fifty-seven infants in the Infant Aphakia Treatment Study (IATS) with a unilateral cataract were randomized to IOL implantation with an initial targeted postoperative refractive error of either +8 diopters (D) (infants 28 to <48 days of age) or +6 D (infants 48-210 days of age). Anisometropia was calculated at age 5 years. Six patients were excluded from the analyses.
Results:
Median age at cataract surgery was 2.2 months (interquartile range [IQR], 1.2, 3.5 months). The mean age at the age 5 years follow-up visit was 5.0 ± 0.1 years (range, 4.9-5.4 years). The median refractive error at the age 5 years visit of the treated eyes was -2.25 D (IQR -5.13, +0.88 D) and of the fellow eyes +1.50 D (IQR +0.88, +2.25). Median anisometropia was -3.50 D (IQR -8.25, -0.88 D); range -19.63 to +2.75 D. Patients with glaucoma in the treated eye (n = 9) had greater anisometropia (glaucoma, median -8.25 D; IQR -11.38, -5.25 D vs no glaucoma median -2.75; IQR -6.38, -0.75 D; P = .005).
Conclusions:
The majority of pseudophakic eyes had significant anisometropia at age 5 years. Anisometropia was greater in patients that developed glaucoma. Variability in eye growth and myopic shift continue to make refractive outcomes challenging for IOL implantation during infancy.
More Related Videos
05:46Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
05:56Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Focusing of Light in the Eye
Angle Closure Glaucoma: Treatment
